First of all I lurk alot and have not posted. I use forums to gauge public opinion on stocks only.
Ok before I go all into the two cents on what is going on we first need to cover Genasense. Genasense is an addition to existing drugs to make them more effective. What this means is that upon approval you are talking about a huge market. Once it is approved once the ball is rolling and follow on approvals are much easier, in addition you will have some off label use. Next and most important a confirmation trial is to back up previous results. What this tells everyone is that the results are positive. Why? The FDA and Genta would not waste time and money to confirm negative results. To do so would make them possibly the dumbest people alive.
So what is going on? Here it is IMO in a nutshell. Genta is going to confirm the results by another trial and this will be approved later this year or next spring. We will probably see a producer jump on board to help produce and possibly market the drug. Also via this producer may financially back this last trial for CLL. Once the gates have opened getting a drug approved for other indications will be much easier. The R/S will be to allow them to get the PPS up if need be and relist on the NASDAQ. This will do two things. Increase upward pressure on the stock by allowing large investment firms to purchase within their operating conditions, this is a win for the shareholders PPS will drive up. Second it gives them a much stronger stance when trying to get financing and signing joint business ventures. This will make it easier for the company to pursue other drugs and develop the rest of the pipeline.
This is why I am in this for Genasense (huge market because it is a complimentary drug) and all the other drugs are just frosting.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.